PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE AS SINGLE AGENTS IN THE TREATMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY

被引:0
|
作者
THIGPEN, JT
BLESSING, JA
FOWLER, WC
HATCH, K
机构
[1] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT MED,DIV ONCOL,JACKSON,MS 39216
[2] UNIV MISSISSIPPI,MED CTR,SCH MED,DEPT OBSTET & GYNECOL,JACKSON,MS 39216
[3] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,GYNECOL ONCOL GRP,BUFFALO,NY 14263
[4] UNIV N CAROLINA,SCH MED,DEPT OBSTET & GYNECOL,DIV GYNECOL ONCOL,CHAPEL HILL,NC 27514
[5] UNIV ALABAMA,DIV GYNECOL ONCOL,BIRMINGHAM,AL 35294
来源
CANCER TREATMENT REPORTS | 1986年 / 70卷 / 09期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1097 / 1100
页数:4
相关论文
共 50 条
  • [1] PHASE-II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED OR RECURRENT NON-SQUAMOUS CELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    SLAYTON, RE
    BLESSING, JA
    HOMESLEY, HD
    CANCER TREATMENT REPORTS, 1984, 68 (12): : 1513 - 1514
  • [2] PHASE-II TRIALS OF CISPLATIN AND PIPERAZINEDIONE IN ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE VULVA - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    HOMESLEY, HD
    LEWIS, GC
    GYNECOLOGIC ONCOLOGY, 1986, 23 (03) : 358 - 363
  • [3] PHASE-II TRIAL OF MAYTANSINE IN TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, T
    EHRLICH, C
    BLESSING, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 424 - 424
  • [4] MITOXANTRONE IN THE TREATMENT OF ADVANCED NON-SQUAMOUS CARCINOMA OF THE CERVIX (A PHASE-II TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP)
    MUSS, HB
    BUNDY, BN
    HOMESLEY, HD
    WILBANKS, G
    INVESTIGATIONAL NEW DRUGS, 1987, 5 (02) : 199 - 202
  • [5] A PHASE-II STUDY OF CARBOPLATIN IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY)
    ARSENEAU, J
    BLESSING, JA
    STEHMAN, FB
    MCGEHEE, R
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 187 - 191
  • [6] A PHASE-II STUDY OF CHIP IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    MCGUIRE, WP
    BLESSING, JA
    HATCH, K
    DISAIA, PJ
    INVESTIGATIONAL NEW DRUGS, 1986, 4 (02) : 181 - 186
  • [7] PHASE-II TRIAL OF PIPERAZINEDIONE (NSC 135758) IN THE TREATMENT OF ADVANCED OR RECURRENT CARCINOMA OF THE OVARY - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    THIGPEN, JT
    BLESSING, JA
    ARSENEAU, JC
    HOMESLEY, HD
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1984, 7 (03): : 261 - 263
  • [8] PHASE-II TRIAL OF PIPERAZINEDIONE (NCS135758) IN THE TREATMENT OF ADVANCED OR RECURRENT SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY
    THIGPEN, JT
    BLESSING, J
    HOMESLEY, HD
    ADCOCK, LL
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1983, 6 (04): : 423 - 426
  • [9] A PHASE-II EVALUATION OF CISPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
    BONOMI, P
    BLESSING, J
    BALL, H
    HANJANI, P
    DISAIA, PJ
    GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 357 - 359
  • [10] Phase II trial of cetuximab in the treatment of persistent or recurrent squamous or non-squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study
    Santin, Alessandro D.
    Sill, Michael W.
    McMeekin, D. Scott
    Leitao, Mario M., Jr.
    Brown, Jubilee
    Sutton, Gregory P.
    Van Le, Linda
    Griffin, Patricia
    Boardman, Cecelia H.
    GYNECOLOGIC ONCOLOGY, 2011, 122 (03) : 495 - 500